Part 7/10:
There was consensus that the FDA's regulation of pharmaceutical ads has been lax, allowing misleading impressions to proliferate. The speakers emphasized that current regulations require fair and balanced information, but enforcement has often fallen short. The proliferation of such advertisements, with their nonstop messaging, has generated frustration among both healthcare professionals and the public, who struggle to discern fact from marketing.